DekaBank Deutsche Girozentrale
AGTC

DekaBank Deutsche Girozentrale’s Applied Genetic Technologies Corporation AGTC Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-8,200
Closed -$113K – 1063
2016
Q1 		$113K Buy
+8,200
New +$120K ﹤0.01% 940

Other funds holding AGTC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

DekaBank Deutsche Girozentrale's AGTC Position: Q2 2016 in Review

DekaBank Deutsche Girozentrale sold out of Applied Genetic Technologies Corporation (AGTC) in Q2 2016, closing a stake of 8,200 shares — an estimated $113K sold.

DekaBank Deutsche Girozentrale first reported a position in AGTC in Q1 2016 and held it in 1 quarter. The position peaked at $113K in Q1 2016. 94 funds tracked by Wall St. Rank hold AGTC as of Q2 2016.

  • DekaBank Deutsche Girozentrale reported no remaining Applied Genetic Technologies Corporation position as of Q2 2016 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 8,200 Applied Genetic Technologies Corporation shares in Q2 2016, an estimated $113K.
  • DekaBank Deutsche Girozentrale first reported a position in Applied Genetic Technologies Corporation in Q1 2016 and held it in 1 quarter.
  • DekaBank Deutsche Girozentrale's Applied Genetic Technologies Corporation position peaked at $113K in Q1 2016.
  • 94 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q2 2016.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2016, filed 4 Aug 2016.